Thursday, February 2, 2012

Geron Completes Enrollment Phase 2 Clinical Trial of Imetelstat in Breast Cancer

That's good news for Geron. Hopefully at the end of this year the results will be great.
Geron closed up 3 cent at $2.02 on avg volume.

ACTC was up 2nd day in a row on 34.3 milion share at .1290 a 7.59% gain. Volume was 49.9 Wed. so I may sell a few shares Friday because the volume was down which to me means the price may follow.
Rumor on Yahoo message board ACTC is talking with Amgen regarding and interesting arrangement.

Good luck in this rigged casino,

No comments:

Post a Comment